ABCA9
gene geneOn this page
Also known as EST640918
Summary
ABCA9 (ATP binding cassette subfamily A member 9, HGNC:39) is a protein-coding gene on chromosome 17q24.2, encoding ATP-binding cassette sub-family A member 9 (Q8IUA7). Transporter that may play a role in monocyte differentiation and lipid transport and homeostasis.
This gene is a member of the superfamily of ATP-binding cassette (ABC) transporters and the encoded protein contains two transmembrane domains and two nucleotide binding folds. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, and White). This gene is a member of the ABC1 subfamily and is clustered with four other ABC1 family members on chromosome 17q24. Transcriptional expression of this gene is induced during monocyte differentiation into macrophages and is suppressed by cholesterol import.
Source: NCBI Gene 10350 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 243 total
- MANE Select transcript:
NM_080283
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:39 |
| Approved symbol | ABCA9 |
| Name | ATP binding cassette subfamily A member 9 |
| Location | 17q24.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | EST640918 |
| Ensembl gene | ENSG00000154258 |
| Ensembl biotype | protein_coding |
| OMIM | 612507 |
| Entrez | 10350 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 4 protein_coding, 3 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000340001, ENST00000453985, ENST00000460872, ENST00000461623, ENST00000482072, ENST00000492580, ENST00000495634, ENST00000585714
RefSeq mRNA: 1 — MANE Select: NM_080283
NM_080283
CCDS: CCDS11681
Canonical transcript exons
ENST00000340001 — 39 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001014884 | 69020388 | 69020586 |
| ENSE00001014888 | 68986164 | 68986324 |
| ENSE00001014889 | 69018413 | 69018579 |
| ENSE00001014892 | 69017656 | 69017789 |
| ENSE00001014895 | 69011976 | 69012083 |
| ENSE00001014898 | 69008062 | 69008235 |
| ENSE00001014899 | 69027640 | 69027815 |
| ENSE00001014901 | 69032108 | 69032276 |
| ENSE00001014906 | 69033726 | 69033873 |
| ENSE00001104867 | 68995895 | 68996014 |
| ENSE00001104878 | 69029169 | 69029227 |
| ENSE00001104907 | 68989027 | 68989118 |
| ENSE00001104910 | 68993016 | 68993084 |
| ENSE00001104921 | 69007759 | 69007872 |
| ENSE00001104926 | 69028535 | 69028645 |
| ENSE00001700840 | 68974488 | 68976013 |
| ENSE00002443807 | 69026377 | 69026467 |
| ENSE00002448457 | 69027330 | 69027449 |
| ENSE00002454710 | 68984885 | 68984979 |
| ENSE00002456941 | 69021742 | 69021861 |
| ENSE00002486934 | 69024214 | 69024353 |
| ENSE00002507898 | 68989813 | 68989930 |
| ENSE00002510781 | 69026976 | 69027114 |
| ENSE00002511572 | 68992175 | 68992266 |
| ENSE00002533378 | 68985053 | 68985128 |
| ENSE00002901142 | 69049283 | 69049490 |
| ENSE00002903675 | 69051031 | 69051139 |
| ENSE00002961687 | 69060866 | 69060927 |
| ENSE00003462405 | 68990837 | 68990957 |
| ENSE00003499236 | 69045172 | 69045336 |
| ENSE00003520650 | 69043489 | 69043715 |
| ENSE00003553476 | 68983709 | 68983849 |
| ENSE00003589811 | 68984056 | 68984175 |
| ENSE00003593093 | 69035246 | 69035431 |
| ENSE00003644223 | 69035660 | 69035801 |
| ENSE00003673237 | 69044497 | 69044600 |
| ENSE00003683159 | 68976135 | 68976190 |
| ENSE00003684079 | 69016253 | 69016390 |
| ENSE00003687509 | 68982562 | 68982641 |
Expression profiles
Bgee: expression breadth ubiquitous, 229 present calls, max score 98.21.
FANTOM5 (CAGE): breadth broad, TPM avg 2.3254 / max 113.6806, expressed in 463 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 167770 | 1.8953 | 438 |
| 167771 | 0.3992 | 174 |
| 167772 | 0.0243 | 6 |
| 167769 | 0.0064 | 4 |
Top tissues by expression
253 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of stomach | UBERON:0001199 | 98.21 | gold quality |
| tibial nerve | UBERON:0001323 | 97.50 | gold quality |
| sural nerve | UBERON:0015488 | 96.41 | gold quality |
| left ovary | UBERON:0002119 | 95.28 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 95.27 | gold quality |
| omental fat pad | UBERON:0010414 | 95.20 | gold quality |
| peritoneum | UBERON:0002358 | 95.14 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 94.46 | gold quality |
| right ovary | UBERON:0002118 | 94.15 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 94.07 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 94.06 | gold quality |
| pericardium | UBERON:0002407 | 93.57 | gold quality |
| apex of heart | UBERON:0002098 | 92.19 | gold quality |
| right atrium auricular region | UBERON:0006631 | 92.18 | gold quality |
| cardiac atrium | UBERON:0002081 | 92.15 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 92.02 | gold quality |
| lower esophagus | UBERON:0013473 | 91.94 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 91.91 | gold quality |
| right lung | UBERON:0002167 | 91.10 | gold quality |
| left uterine tube | UBERON:0001303 | 91.08 | gold quality |
| right coronary artery | UBERON:0001625 | 91.08 | gold quality |
| adipose tissue | UBERON:0001013 | 91.04 | gold quality |
| ovary | UBERON:0000992 | 90.25 | gold quality |
| endocervix | UBERON:0000458 | 89.39 | gold quality |
| gastrocnemius | UBERON:0001388 | 89.35 | gold quality |
| calcaneal tendon | UBERON:0003701 | 89.30 | gold quality |
| heart | UBERON:0000948 | 89.11 | gold quality |
| heart left ventricle | UBERON:0002084 | 88.95 | gold quality |
| left coronary artery | UBERON:0001626 | 88.69 | gold quality |
| coronary artery | UBERON:0001621 | 88.63 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-180759 | yes | 1652.15 |
| E-ANND-3 | yes | 40.50 |
| E-HCAD-35 | yes | 6.65 |
| E-MTAB-7606 | no | 5.55 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- Novel key genes in triple-negative breast cancer identified by weighted gene co-expression network analysis. (PMID:31081967)
- ABCA9, an ER cholesterol transporter, inhibits breast cancer cell proliferation via SREBP-2 signaling. (PMID:36576228)
Cross-species orthologs
16 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | abca5 | ENSDARG00000074041 |
| mus_musculus | Abca9 | ENSMUSG00000041797 |
| rattus_norvegicus | Abca9 | ENSRNOG00000059326 |
| drosophila_melanogaster | Eato | FBGN0028539 |
| drosophila_melanogaster | CG1494 | FBGN0031169 |
| drosophila_melanogaster | Abca3 | FBGN0031170 |
| drosophila_melanogaster | CG1801 | FBGN0031171 |
| drosophila_melanogaster | CG8908 | FBGN0034493 |
| drosophila_melanogaster | CG6052 | FBGN0036747 |
| drosophila_melanogaster | CG31213 | FBGN0051213 |
| drosophila_melanogaster | ldd | FBGN0083956 |
| drosophila_melanogaster | CG43672 | FBGN0263747 |
| caenorhabditis_elegans | WBGENE00000019 | |
| caenorhabditis_elegans | abt-2 | WBGENE00000020 |
| caenorhabditis_elegans | WBGENE00000022 | |
| caenorhabditis_elegans | abt-5 | WBGENE00000023 |
Paralogs (11): ABCA7 (ENSG00000064687), ABCA2 (ENSG00000107331), ABCA8 (ENSG00000141338), ABCA12 (ENSG00000144452), ABCA6 (ENSG00000154262), ABCA10 (ENSG00000154263), ABCA5 (ENSG00000154265), ABCA1 (ENSG00000165029), ABCA3 (ENSG00000167972), ABCA13 (ENSG00000179869), ABCA4 (ENSG00000198691)
Protein
Protein identifiers
ATP-binding cassette sub-family A member 9 — Q8IUA7 (reviewed: Q8IUA7)
All UniProt accessions (3): Q8IUA7, H0Y4U7, K7EJJ0
UniProt curated annotations — full annotation on UniProt →
Function. Transporter that may play a role in monocyte differentiation and lipid transport and homeostasis.
Subcellular location. Membrane.
Tissue specificity. Widely expressed with higher expression in heart.
Induction. Up-regulated during monocyte differentiation into macrophages. Down-regulated by cholesterol loading of macrophages.
Similarity. Belongs to the ABC transporter superfamily. ABCA family.
Isoforms (5)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8IUA7-1 | 1 | yes |
| Q8IUA7-2 | 2, ABCA9delta+55 | |
| Q8IUA7-3 | 3, ABCA9delta+73 | |
| Q8IUA7-4 | 4, ABCA9delta-95 | |
| Q8IUA7-5 | 5 |
RefSeq proteins (1): NP_525022* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003439 | ABC_transporter-like_ATP-bd | Domain |
| IPR003593 | AAA+_ATPase | Domain |
| IPR013525 | ABC2_TM | Domain |
| IPR026082 | ABCA | Family |
| IPR027417 | P-loop_NTPase | Homologous_superfamily |
Pfam: PF00005, PF12698
UniProt features (32 total): transmembrane region 14, splice variant 5, sequence variant 4, glycosylation site 3, domain 2, binding site 2, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IUA7-F1 | 77.22 | 0.14 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (2): 517–524; 1326–1333
Glycosylation sites (3): 120, 195, 949
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-1369062 | ABC transporters in lipid homeostasis |
| R-HSA-382551 | Transport of small molecules |
| R-HSA-382556 | ABC-family protein mediated transport |
MSigDB gene sets: 91 (showing top):
IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR, KEGG_ABC_TRANSPORTERS, TGTGTGA_MIR377, COATES_MACROPHAGE_M1_VS_M2_UP, GOBP_LIPID_LOCALIZATION, NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON, CAGCCTC_MIR4855P, GOBP_TRANSMEMBRANE_TRANSPORT, GOMF_LIPID_TRANSPORTER_ACTIVITY, GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ACID_ANHYDRIDES, GOMF_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_ATP_HYDROLYSIS_ACTIVITY, GOMF_ADENYL_NUCLEOTIDE_BINDING, GOMF_TRANSPORTER_ACTIVITY, CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP
GO Biological Process (2): lipid transport (GO:0006869), transmembrane transport (GO:0055085)
GO Molecular Function (6): lipid carrier activity (GO:0005319), ATP binding (GO:0005524), ATP hydrolysis activity (GO:0016887), ATPase-coupled transmembrane transporter activity (GO:0042626), ABC-type transporter activity (GO:0140359), nucleotide binding (GO:0000166)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| ABC-family protein mediated transport | 1 |
| Transport of small molecules | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transport | 2 |
| ATP-dependent activity | 2 |
| lipid localization | 1 |
| cellular process | 1 |
| molecular carrier activity | 1 |
| adenyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| ribonucleoside triphosphate phosphatase activity | 1 |
| primary active transmembrane transporter activity | 1 |
| ATP hydrolysis activity | 1 |
| ATPase-coupled transmembrane transporter activity | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
872 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ABCA9 | ABCC3 | O15438 | 459 |
| ABCA9 | ABCC9 | O60706 | 457 |
| ABCA9 | ABCD4 | O14678 | 443 |
| ABCA9 | ABCF3 | Q9NUQ8 | 389 |
| ABCA9 | ABCF1 | Q8NE71 | 362 |
| ABCA9 | OR56B4 | Q8NH76 | 348 |
| ABCA9 | ZFAND4 | Q86XD8 | 311 |
| ABCA9 | LYPD2 | Q6UXB3 | 300 |
| ABCA9 | ABCA13 | Q86UQ4 | 284 |
| ABCA9 | PCOLCE2 | Q9UKZ9 | 282 |
| ABCA9 | ABCC8 | Q09428 | 281 |
| ABCA9 | SLC37A3 | Q8NCC5 | 279 |
| ABCA9 | ABCA12 | Q86UK0 | 278 |
| ABCA9 | ABCB8 | Q9NUT2 | 277 |
| ABCA9 | SLC16A14 | Q7RTX9 | 274 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| MYC | psi-mi:“MI:0914”(association) | 0.350 | |
| ABCA10 | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
| ABCA9 | SERPINB8 | psi-mi:“MI:0914”(association) | 0.350 |
| ABCA9 | PMM2 | psi-mi:“MI:0914”(association) | 0.350 |
| ABCA9 | DEDD | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (9): ABCA9 (Two-hybrid), ABCA9 (Affinity Capture-MS), SERPINB8 (Affinity Capture-MS), BLK (Affinity Capture-MS), GET4 (Affinity Capture-MS), PMM1 (Affinity Capture-MS), PMM2 (Affinity Capture-MS), ABCA9 (Cross-Linking-MS (XL-MS)), EEA1 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0A0G2K1Q8, B2RX12, E9PU17, E9PX95, F1MWM0, O00329, O15438, O35600, O75899, O88563, O88871, O94911, O95477, P41233, P55205, P58428, P78363, Q09427, Q09428, Q09429, Q2NKY8, Q5BJS0, Q5R607, Q5ZI74, Q6TL19, Q7L2E3, Q7TNJ2, Q80T41, Q84M24, Q8CF82, Q8IUA7, Q8K440, Q8K441, Q8K442, Q8K448, Q8K449, Q8LPK0, Q8N139, Q8NCL4, Q8R420
Diamond homologs: A0A059J0G5, A0A0G2K1Q8, A0A1L9WQK0, A0A1U8QKX8, A0A1U8QT10, A0A1V0QSE4, A0A1V1GB10, A0A1Y0BRF0, A0A2H1A768, A0A2U8U2K9, A0A481WQK1, A0A4P8GG95, A0A8K1AW53, A1C8C8, A1CFM0, A9YWR6, B6HV31, B6RAL1, B8NDS8, B9G5Y5, D3GE74, D4AYW0, D4GSY7, E9PU17, E9PX95, E9RBG1, F2PLH2, F2RSQ6, F2SG60, F2SHL1, G3JF11, I1RL06, J9VME1, J9VPA2, M2UCE5, O42690, O65934, O74208, O74676, P10090
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
243 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 203 |
| Likely benign | 20 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
5607 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:68975925:T:A | donor_gain | 1.0000 |
| 17:68976011:AACC:A | acceptor_loss | 1.0000 |
| 17:68976013:CCTAA:C | acceptor_loss | 1.0000 |
| 17:68976014:CTAA:C | acceptor_loss | 1.0000 |
| 17:68976191:C:CC | acceptor_gain | 1.0000 |
| 17:68983705:CTA:C | donor_loss | 1.0000 |
| 17:68983706:TACCT:T | donor_loss | 1.0000 |
| 17:68983707:ACC:A | donor_loss | 1.0000 |
| 17:68983708:CCT:C | donor_loss | 1.0000 |
| 17:68983712:T:A | donor_gain | 1.0000 |
| 17:68983845:TACAT:T | acceptor_gain | 1.0000 |
| 17:68983847:CAT:C | acceptor_gain | 1.0000 |
| 17:68983849:TCT:T | acceptor_loss | 1.0000 |
| 17:68983850:C:CC | acceptor_gain | 1.0000 |
| 17:68983850:CTGA:C | acceptor_loss | 1.0000 |
| 17:68984049:CACT:C | donor_loss | 1.0000 |
| 17:68984050:ACTC:A | donor_loss | 1.0000 |
| 17:68984051:CTCA:C | donor_loss | 1.0000 |
| 17:68984052:TCAC:T | donor_loss | 1.0000 |
| 17:68984053:CACCT:C | donor_loss | 1.0000 |
| 17:68984055:C:CG | donor_loss | 1.0000 |
| 17:68984174:GC:G | acceptor_gain | 1.0000 |
| 17:68984175:CC:C | acceptor_gain | 1.0000 |
| 17:68985047:CCGTA:C | donor_loss | 1.0000 |
| 17:68985048:CGTAC:C | donor_loss | 1.0000 |
| 17:68985049:GTACC:G | donor_loss | 1.0000 |
| 17:68985050:TA:T | donor_loss | 1.0000 |
| 17:68985051:ACC:A | donor_loss | 1.0000 |
| 17:68985052:C:A | donor_loss | 1.0000 |
| 17:68985124:CTAAC:C | acceptor_gain | 1.0000 |
AlphaMissense
10699 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:69016319:G:C | S991R | 0.992 |
| 17:69016319:G:T | S991R | 0.992 |
| 17:69016321:T:G | S991R | 0.992 |
| 17:69027010:G:C | S672R | 0.991 |
| 17:69027010:G:T | S672R | 0.991 |
| 17:69027012:T:G | S672R | 0.991 |
| 17:69035276:G:C | S366R | 0.990 |
| 17:69035276:G:T | S366R | 0.990 |
| 17:69035278:T:G | S366R | 0.990 |
| 17:68989079:T:A | K1332I | 0.988 |
| 17:69028609:G:T | A514D | 0.987 |
| 17:69044511:C:G | A187P | 0.987 |
| 17:69017682:C:G | A959P | 0.986 |
| 17:69026410:A:G | L703P | 0.986 |
| 17:69028582:T:A | K523I | 0.986 |
| 17:69044536:A:C | F178L | 0.985 |
| 17:69044536:A:T | F178L | 0.985 |
| 17:69044538:A:G | F178L | 0.985 |
| 17:69026406:C:A | K704N | 0.984 |
| 17:69026406:C:G | K704N | 0.984 |
| 17:69027364:A:G | L626P | 0.982 |
| 17:69024243:A:G | L751S | 0.981 |
| 17:69027692:A:G | L580P | 0.981 |
| 17:68989075:A:C | S1333R | 0.979 |
| 17:68989075:A:T | S1333R | 0.979 |
| 17:68989077:T:G | S1333R | 0.979 |
| 17:69016346:G:C | C982W | 0.978 |
| 17:69044548:C:A | W174C | 0.977 |
| 17:69044548:C:G | W174C | 0.977 |
| 17:69045221:A:C | F140L | 0.977 |
dbSNP variants (sampled 300 via entrez): RS1000031406 (17:69043311 A>G), RS1000036002 (17:69004262 G>A,T), RS1000056733 (17:69050390 A>G), RS1000121805 (17:69062869 T>C), RS1000174919 (17:69013845 T>G), RS1000220360 (17:68978781 A>G), RS1000223047 (17:68991898 A>G), RS1000240268 (17:69015649 G>C), RS1000311054 (17:69074356 C>T), RS1000321574 (17:69028880 G>A,C), RS1000344004 (17:69073969 T>A), RS1000469189 (17:68993186 C>G), RS1000485118 (17:68990478 C>G,T), RS1000527925 (17:69008648 G>C), RS1000529384 (17:69008349 C>A,T)
Disease associations
OMIM: gene MIM:612507 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008176_4 | Gestational age at birth (child effect) | 5.000000e-06 |
| GCST009533_5 | Circulating leptin levels x sex interaction in high cardiovascular risk | 9.000000e-06 |
| GCST012310_10 | Schizophrenia x sex interaction | 3.000000e-06 |
| GCST012311_26 | Schizophrenia x sex interaction | 5.000000e-06 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005112 | gestational age |
| EFO:0005000 | leptin measurement |
| EFO:0008343 | sex interaction measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — ABCA subfamily
CTD chemical–gene interactions
17 total (human), top 17 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Nickel | decreases expression | 2 |
| bisphenol A | increases methylation | 1 |
| lead acetate | decreases expression | 1 |
| mono-(2-ethylhexyl)phthalate | decreases expression | 1 |
| manganese chloride | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | increases expression | 1 |
| incobotulinumtoxinA | increases expression | 1 |
| Docetaxel | decreases response to substance, increases expression | 1 |
| Arsenic Trioxide | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cadmium | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Manganese | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.